What is the Future of BET Inhibitors in Cancer Therapy?
The future of BET inhibitors in cancer therapy looks promising, with ongoing research focused on improving their efficacy and safety profiles. Combination therapies involving BET inhibitors and other anticancer agents, such as chemotherapy, targeted therapies, and immunotherapies, are being explored to enhance treatment outcomes. Additionally, efforts are underway to identify biomarkers that can predict patient response to BET inhibitors, enabling more personalized and effective treatment strategies.
